Aala Fazli

Pharmaceutics researcher specializing in oral controlled-release drug delivery systems, in vitro–in vivo relationship (IVIVR) development, and preclinical pharmacokinetic evaluation. Experienced in formulation design, hydrophilic polymer matrix systems, and solid-state characterization of drug substances. Author of peer-reviewed publications in Scientific Reports, AAPS PharmSciTech, and Journal of Drug Delivery Science & Technology, with research and industrial R&D training at Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd.

Research focuses on mechanistic understanding of drug release, dissolution–absorption behavior, and translational development of extended-release dosage forms.

Product Development Research (PDR) Trainee (PhD Research Training) - Sun Pharmaceutical Industries Ltd. - Gurugram, India

13 months

• Extended-release formulation development
• Dissolution profiling and IVIVR-oriented studies
• Hands-on experience in QbD-oriented formulation development and scale-up
• Exposure to industrial R&D workflow and regulatory documentation

Oral Controlled Release Systems (OCRS) Research Trainee (MPharm Research Training) - Ranbaxy Laboratories Ltd. (now Sun Pharma) - Gurugram, India

12 months

• Hydrophilic matrix tablet formulation
• Polymer functionality and release mechanism evaluation
• Process optimization studies

Trainee Executive – Production & Quality Control (BPharm Training) - Eaton Laboratories - Srinagar, India

6 months

• Tablet manufacturing and quality control testing
• Process documentation and in-process evaluation

PhD - Pharmaceutics - University of Kashmir

MPharm - Pharmaceutics - University of Kashmir

BPharm - Pharmacy - University of Kashmir